Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Completed1
Recruiting1
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

completed125%
recruiting125%
terminated125%
not_yet_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruitingphase_1

The Safety and PK Study of Inhaled ICF004 in Healthy Chinese Volunteers

NCT07719218
recruitingnot_applicable

Sleep Promoting Properties of a Botanical Extract in a Population Complaining From Non-Restorative Sleep (NRS)

NCT07085819
terminatednot_applicable

Aerobic Fitness in Overweight and Obese Individuals

NCT03854786
completednot_applicable

Effect of Proton Pump Inhibitors on Palpitations

NCT02826408

Clinical Trials (4)

Showing 4 of 4 trials
NCT07719218Phase 1

The Safety and PK Study of Inhaled ICF004 in Healthy Chinese Volunteers

Not Yet Recruiting
NCT07085819Not Applicable

Sleep Promoting Properties of a Botanical Extract in a Population Complaining From Non-Restorative Sleep (NRS)

Recruiting
NCT03854786Not Applicable

Aerobic Fitness in Overweight and Obese Individuals

Terminated
NCT02826408Not Applicable

Effect of Proton Pump Inhibitors on Palpitations

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4